One of the most common questions about stem cells is economic as patients ask about stem cell treatment cost. How much is the price tag? Empowered with information patients can start thinking like consumers and look out for their own interests more vigorously. I’ve blogged and done polls before about how much patients self-report having paid […]
Stem cell treatment poll results: how repeat shots boost costs Read More »
Stem cells for arthritis and pain are hot topics these days and I’m getting an increasing number of patients reaching out with questions and sharing their situations related to arthritis or pain (or usually both together). I asked one arthritis patient who reached out to me if they would be OK with me sharing their
Arthritis patient with pain’s email on stem cell clinic & my answer Read More »
Who decides whether a stem cell therapy is “good” or “bad”, and should that kind of a judgment be more focused on direct patient perspectives such as their stem cell therapy reviews as consumers or based on biomedical science? Both? I’ve written before about how stem cell patients are increasingly thinking of themselves as consumers
Stem cell therapy reviews: knees, lung, autism, & Regenexx Read More »
Remember that Shoukhrat Mitalipov lab paper on the use of CRISPR in human embryos? It’s back in the news. One of the biggest stories of 2017 centered on a Nature paper (Ma, et al., see my quick, initial review shortly after it was published here) from Mitalipov’s lab claiming both efficient repair of a disease-causing
Mitalipov rebuts CRISPR pub critiques: strengthens case, but puzzles remain Read More »
For years I’ve been working on an educational outreach program that I call SCOPE, for stem cell outreach program for education that translates a concise stem cell white paper I wrote with key basic and clinical stem cell information into as many languages as possible. Now with the addition of Czech with thanks to translator
Stem Cells Not Lost in Translation Project: Now up to 33 languages with Czech Read More »
What do you get when celebrity podcaster Joe Rogan talks about stem cells? There can be big impact one way or another. I don’t believe his shows on stem cells have helped provide solid info. What do I mean? Patients can be strongly influenced by what they see on social media and YouTube videos pack
Deconstructing Joe Rogan promotional stem cell video with Mel Gibson Read More »
One of the reasons I’m a scientist is that I find biology fascinating and admittedly novel biomedical science can really catch my eye, but more recently as a somewhat grizzled researcher, I’ve become increasingly skeptical about some “sexy” research and media coverage of it. A small red flag went up for me as I was
Perspectives on uncritical NYT coverage of cardiac mitochondrial transplant trial Read More »
Every year in December I go out onto a limb and make stem cell predictions for the coming year as I did in late 2017 for this year. Then usually around the 1/2-way point through the year I check in on how the predictions are faring so far at that point. In this post I give
Midterm grades on my 20 x 2018 stem cell predictions Read More »
I have a new Cell Stem Cell piece out today that aims to take stock of today’s stem cell regulatory oversight in the U.S., Japan, and elsewhere including Australia, Canada and India. I use a carrot and stick metaphor for encouraging legit research and taking regulatory action on serious non-compliant activities, respectively. Where is stem cell
My new Cell Stem Cell piece: too much carrot & not enough stick on stem cell oversight Read More »
Could potential associated cancer risks claw into CRISPR’s potential? The short answer from both previous and new data is that while CRISPR gene editing impacts the P53 pathway, which is involved in cancer along with having many other functions, this news is neither too surprising nor a fatal flaw, but some caution is warranted. CRISPR
Could Cancer Risk Claw CRISPR’s Potential? Some Balanced Perspectives Read More »